Larvol Delta - Phase-1-Safety-Tolerability-PK-amp-PD-Study-of-AD214-Administered-to-Healthy-Volunteers

AD-214 - AdAlta

http://clinicaltrials.gov/ct2/show/NCT04415671

May 6, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next